Post-Operative Sequel of Complex Vesico Vaginal Fistula
DOI:
https://doi.org/10.70749/ijbr.v3i7.1749Keywords:
Vesicovaginal fistula, surgical repair, postoperative outcomes, complex fistula, interposition flapAbstract
Introduction: Complex vesicovaginal fistula (VVF) is a debilitating condition that often results from obstetric trauma, surgical injury, or radiation, posing significant challenges to surgical repair and postoperative recovery. Objective: To assess the impact of surgical repair in complex vesicovaginal fistula patients. To assess the impact of surgical repair in patients with complex vesicovaginal fistula. Materials and Method: The study was done prospectively at a prospective observational study at Department of Urology, Armed Forces Institute of Urology from January 03, 2025 and May 15, 2025. Thirty-two complex VVF patients were recruited. Based on the nature of the fistula, surgical repairs were done by using a transvaginal or transabdominal fashion. Two and six weeks were used to investigate postoperative numbers. Results: There was complete closure in 81.25 percent of the patients. There was partial healing in 12.5% and failed repair in 6.25%. Tissue flaps and use were linked with a better surgical outcome. There were worse prognoses of radiation-induced and recurrent fistulae. Conclusion: Surgical repair of complex VVF yields favorable outcomes when guided by careful assessment, technique, and postoperative care, though prevention remains crucial.
Downloads
References
1. Ninan, K., Liyanage, S.K., Murphy, K.E., Asztalos, E.V. and McDonald, S.D., 2022. Evaluation of long-term outcomes associated with preterm exposure to antenatal corticosteroids: a systematic review and meta-analysis. JAMA pediatrics, 176(6), pp.e220483-e220483.
https://doi.org/10.1001/jamapediatrics.2022.0483
2. Ninan, K., Gojic, A., Wang, Y., Asztalos, E.V., Beltempo, M., Murphy, K.E. and McDonald, S.D., 2023. The proportions of term or late preterm births after exposure to early antenatal corticosteroids, and outcomes: systematic review and meta-analysis of 1.6 million infants. bmj, 382.
https://doi.org/10.1136/bmj-2023-076035
3. Üstün, N., Hocaoğlu, M., Turgut, A., Arslanoğlu, S. and Ovalı, F., 2022. Does antenatal corticosteroid therapy improve neonatal outcomes in late preterm birth?. The Journal of Maternal-Fetal & Neonatal Medicine, 35(1), pp.11-17.
https://doi.org/10.1080/14767058.2020.1808614
4. Aviram, A., Murphy, K., McDonald, S., Asztalos, E., Zaltz, A., Redelmeier, D., Shah, B., Barrett, J. and Melamed, N., 2022. Antenatal corticosteroids and neurodevelopmental outcomes in late preterm births. Archives of Disease in Childhood-Fetal and Neonatal Edition, 107(3), pp.250-255.
https://doi.org/10.1136/archdischild-2021-322152
5. Reddy, U.M., Deshmukh, U., Dude, A., Harper, L., Osmundson, S.S. and Society for Maternal-Fetal Medicine (SMFM, 2021. Society for Maternal-Fetal Medicine Consult Series# 58: Use of antenatal corticosteroids for individuals at risk for late preterm delivery: Replaces SMFM Statement# 4, Implementation of the use of antenatal corticosteroids in the late preterm birth period in women at risk for preterm delivery, August 2016. American journal of obstetrics and gynecology, 225(5), pp.B36-B42.
https://doi.org/10.1016/j.ajog.2021.07.023
6. Vogel, J.P., Ramson, J., Darmstadt, G.L., Qureshi, Z.P., Chou, D., Bahl, R. and Oladapo, O.T., 2022. Updated WHO recommendations on antenatal corticosteroids and tocolytic therapy for improving preterm birth outcomes. The Lancet Global Health, 10(12), pp.e1707-e1708.
https://doi.org/10.1016/s2214-109x(22)00434-x
7. Norman, J., Shennan, A., Jacobsson, B., Stock, S.J., FIGO Working Group for Preterm Birth, Simpson, J.L., Bianchi, A., Munjanja, S., González, C.M.V. and Mol, B.W., 2021. FIGO good practice recommendations on the use of prenatal corticosteroids to improve outcomes and minimize harm in babies born preterm. International Journal of Gynecology & Obstetrics, 155(1), pp.26-30.
https://doi.org/10.1002/ijgo.13836
8. Ninan, K., Morfaw, F., Murphy, K.E., Beyene, J. and McDonald, S.D., 2021. Neonatal and maternal outcomes of lower versus standard doses of antenatal corticosteroids for women at risk of preterm delivery: a systematic review of randomized controlled trials. Journal of Obstetrics and Gynaecology Canada, 43(1), pp.74-81.
https://doi.org/10.1016/j.jogc.2020.02.127
9. Hamm, R.F., Combs, C.A., Aghajanian, P., Friedman, A.M., Society for Maternal-Fetal Medicine (SMFM and Quality Committee, 2022. Society for Maternal-Fetal Medicine Special Statement: Quality metrics for optimal timing of antenatal corticosteroid administration. American Journal of Obstetrics and Gynecology, 226(6), pp.B2-B10.
https://doi.org/10.1016/j.ajog.2022.02.021
10. McKinzie, A.H., Yang, Z., Teal, E., Daggy, J.K., Tepper, R.S., Quinney, S.K., Rhoads, E., Haneline, L.S. and Haas, D.M., 2021. Are newborn outcomes different for term babies who were exposed to antenatal corticosteroids?. American journal of obstetrics and gynecology, 225(5), pp.536-e1.
https://doi.org/10.1016/j.ajog.2021.04.251
11. Deshmukh, M. and Patole, S., 2021. Antenatal corticosteroids for impending late preterm (34-36+ 6 weeks) deliveries—A systematic review and meta-analysis of RCTs. PLoS One, 16(3), p.e0248774.
https://doi.org/10.1371/journal.pone.0248774
12. Gulersen, M., Gyamfi-Bannerman, C., Greenman, M., Lenchner, E., Rochelson, B. and Bornstein, E., 2021. Time interval from late preterm antenatal corticosteroid administration to delivery and the impact on neonatal outcomes. American Journal of Obstetrics & Gynecology MFM, 3(5), p.100426.
https://doi.org/10.1016/j.ajogmf.2021.100426
13. Gyamfi-Bannerman, C., Clifton, R.G., Tita, A.T., Blackwell, S.C., Longo, M., De Voest, J.A., O’Shea, T.M., Bousleiman, S.Z., Ortiz, F., Rouse, D.J. and Metz, T.D., 2024. Neurodevelopmental outcomes after late preterm antenatal corticosteroids: the ALPS follow-up study. JAMA, 331(19), pp.1629-1637.
https://doi.org/10.1001/jama.2024.4303
14. Kearsey, E.O., Been, J.V., Souter, V.L. and Stock, S.J., 2022. The impact of the Antenatal Late Preterm Steroids trial on the administration of antenatal corticosteroids. American Journal of Obstetrics and Gynecology, 227(2), pp.280-e1.
https://doi.org/10.1016/j.ajog.2022.03.037
15. Daskalakis, G., Pergialiotis, V., Domellöf, M., Ehrhardt, H., Di Renzo, G.C., Koç, E., Malamitsi-Puchner, A., Kacerovsky, M., Modi, N., Shennan, A. and Ayres-de-Campos, D., 2023. European guidelines on perinatal care: corticosteroids for women at risk of preterm birth. The Journal of Maternal-Fetal & Neonatal Medicine, 36(1), p.2160628.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
